Cargando…
Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis
The human gastrointestinal tract (GIT) is highly colonized by bacterial communities, which live in a symbiotic relationship with the host in normal conditions. It has been shown that a dysfunctional interaction between the intestinal microbiota and the host immune system, known as dysbiosis, is a ve...
Autores principales: | Carvalho, Rodrigo D. De Oliveira, do Carmo, Fillipe L. R., de Oliveira Junior, Alberto, Langella, Philippe, Chatel, Jean-Marc, Bermúdez-Humarán, Luis G., Azevedo, Vasco, de Azevedo, Marcela S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422521/ https://www.ncbi.nlm.nih.gov/pubmed/28536562 http://dx.doi.org/10.3389/fmicb.2017.00800 |
Ejemplares similares
-
Development of Mucosal Vaccines Based on Lactic Acid Bacteria
por: Bermúdez-Humarán, Luis G., et al.
Publicado: (2009) -
Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models
por: de Moreno de LeBlanc, Alejandra, et al.
Publicado: (2015) -
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines
por: Bermúdez-Humarán, Luis G, et al.
Publicado: (2011) -
Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease
por: Martín, Rebeca, et al.
Publicado: (2013) -
Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis
por: Carvalho, Rodrigo D., et al.
Publicado: (2017)